PMC:7402624 / 39996-40277 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T369","span":{"begin":47,"end":52},"obj":"Body_part"},{"id":"T370","span":{"begin":119,"end":127},"obj":"Body_part"}],"attributes":[{"id":"A369","pred":"fma_id","subj":"T369","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A370","pred":"fma_id","subj":"T370","obj":"http://purl.org/sig/ont/fma/fma62871"}],"text":"Increases in proliferating KI67+ CD4 and CD8 T cells over time were positively correlated to increasing anti-SARS-CoV2 antibody from day 0 to day 7, suggesting that some individuals might have been hospitalized during the expansion phase of the antiviral immune response (Fig. 5G)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"1429","span":{"begin":33,"end":36},"obj":"Gene"},{"id":"1434","span":{"begin":41,"end":44},"obj":"Gene"},{"id":"1441","span":{"begin":109,"end":118},"obj":"Species"}],"attributes":[{"id":"A1429","pred":"tao:has_database_id","subj":"1429","obj":"Gene:920"},{"id":"A1434","pred":"tao:has_database_id","subj":"1434","obj":"Gene:925"},{"id":"A1441","pred":"tao:has_database_id","subj":"1441","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Increases in proliferating KI67+ CD4 and CD8 T cells over time were positively correlated to increasing anti-SARS-CoV2 antibody from day 0 to day 7, suggesting that some individuals might have been hospitalized during the expansion phase of the antiviral immune response (Fig. 5G)."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T310","span":{"begin":109,"end":113},"obj":"Disease"}],"attributes":[{"id":"A310","pred":"mondo_id","subj":"T310","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"Increases in proliferating KI67+ CD4 and CD8 T cells over time were positively correlated to increasing anti-SARS-CoV2 antibody from day 0 to day 7, suggesting that some individuals might have been hospitalized during the expansion phase of the antiviral immune response (Fig. 5G)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T677","span":{"begin":33,"end":36},"obj":"http://purl.obolibrary.org/obo/PR_000001004"},{"id":"T678","span":{"begin":41,"end":44},"obj":"http://purl.obolibrary.org/obo/CLO_0053438"},{"id":"T679","span":{"begin":45,"end":52},"obj":"http://purl.obolibrary.org/obo/CL_0000084"}],"text":"Increases in proliferating KI67+ CD4 and CD8 T cells over time were positively correlated to increasing anti-SARS-CoV2 antibody from day 0 to day 7, suggesting that some individuals might have been hospitalized during the expansion phase of the antiviral immune response (Fig. 5G)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T277","span":{"begin":245,"end":254},"obj":"Chemical"}],"attributes":[{"id":"A277","pred":"chebi_id","subj":"T277","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"}],"text":"Increases in proliferating KI67+ CD4 and CD8 T cells over time were positively correlated to increasing anti-SARS-CoV2 antibody from day 0 to day 7, suggesting that some individuals might have been hospitalized during the expansion phase of the antiviral immune response (Fig. 5G)."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T88","span":{"begin":255,"end":270},"obj":"http://purl.obolibrary.org/obo/GO_0006955"}],"text":"Increases in proliferating KI67+ CD4 and CD8 T cells over time were positively correlated to increasing anti-SARS-CoV2 antibody from day 0 to day 7, suggesting that some individuals might have been hospitalized during the expansion phase of the antiviral immune response (Fig. 5G)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T232","span":{"begin":0,"end":281},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Increases in proliferating KI67+ CD4 and CD8 T cells over time were positively correlated to increasing anti-SARS-CoV2 antibody from day 0 to day 7, suggesting that some individuals might have been hospitalized during the expansion phase of the antiviral immune response (Fig. 5G)."}